1060802-24-5Relevant articles and documents
TOLL-LIKE RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USE
-
Paragraph 0319, (2018/05/27)
The invention relates to compounds of formula (I): or a salt or solvate thereof, wherein the variables are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are antagonists of toll-like receptors such as TLR7, TLR8 and/or TLR9 that are useful for inhibiting immune response and treating diseases associated with undesirable immune response.
CONDENSED RING DERIVATIVE, AND PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE THEREOF
-
Paragraph 0235; 0236, (2018/02/28)
Disclosed are a condensed ring derivative, and a preparation method, an intermediate, a pharmaceutical composition and a use thereof. The condensed ring derivative of the present invention has a significant inhibitive effect on URAT1, which can effectively alleviate or treat hyperuricemia and other related diseases.
Derivatives of sulfur-containing heterocyclic carboxylic acids and preparation method and application thereof
-
Paragraph 0408; 0410; 0411; 0454; 0456, (2017/06/21)
The invention belongs to the field of medicines and particularly relates to derivatives of a series of sulfur-containing heterocyclic carboxylic acids, officinal salts thereof, a preparation method of pharmaceutically acceptable prodrugs, drug compositions including derivatives and application of the derivatives and the drug compositions in preparation of anti-gout drugs and treatment of related diseases.